The overall goals of this application are to establish the natural history of cyst progression prior to the development of renal insufficiency and to identify imaging and biochemical parameters which can be used as surrogate markers of disease activity of progression in polycystic kidney disease.
Specific aims i nclude: 1) Determine the rate of change of renal cysts and parenchyma volumes and of renal blood flow, their dependency on age, gender, ethnic background, and PKD genotype, and their correlation with other possible biochemical markers of disease activity or progression in prepubertal, pubertal and young adult patients with ADPKD (7-20 years) diagnosed for the purpose of the study and in non- affected sibling. 2) Determine the predictive value of absolute and relative renal cyst and parenchyma volumes, of renal blood flow, and of their changes over time, and of biochemical markers of disease activity for the rate of decline of renal function measured by serum cyst cystatin C levels and non-radiolabeled iothalamate clearance in patients with ADPKD and normal serum creatinine at the onset of the study. 3) Determine the rate of change of renal cyst and parenchyma volumes, renal blood flow, and biochemical markers of disease activity associated with pregnancy in ADPKD. 4) Study the renal cyst and parenchyma volumes, renal blood flow, and biochemical markers of disease activity associated with pregnancy in ADPKD. 4) Study the renal cyst and parenchyma v and parenchyma volumes, renal blood flow, liver imaging parameters, and biochemical markers of disease activity or progression in children with symptomatic early onset ADPKD or ARPKD and variable degrees of renal dysfunction. 5) Study the mechanical properties of the renal and hepatic parenchyma in ADPKD and ARPKD, using MR elastography. We propose to use innovative imaging studies based on state-of-the-art MR technology and 3d ultrasound. We anticipate that the results of this study will provide further insight into the pathogenesis of polycystic kidney disease and will facilitate the design of future intervention trials, shortening the observation period necessary to determine efficacy.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01DK056957-04
Application #
6624915
Study Section
Special Emphasis Panel (ZDK1-GRB-7 (O1))
Program Officer
Flessner, Michael Francis
Project Start
2000-02-01
Project End
2004-11-30
Budget Start
2002-12-01
Budget End
2003-11-30
Support Year
4
Fiscal Year
2003
Total Cost
$500,000
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Yu, Alan S L; Shen, Chengli; Landsittel, Douglas P et al. (2018) Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease. Kidney Int 93:691-699
Cornec-Le Gall, Emilie; Olson, Rory J; Besse, Whitney et al. (2018) Monoallelic Mutations to DNAJB11 Cause Atypical Autosomal-Dominant Polycystic Kidney Disease. Am J Hum Genet 102:832-844
McKenzie, Katelyn A; El Ters, Mirelle; Torres, Vicente E et al. (2018) Relationship between caffeine intake and autosomal dominant polycystic kidney disease progression: a retrospective analysis using the CRISP cohort. BMC Nephrol 19:378
Shen, Chengli; Landsittel, Douglas; Irazabal, María V et al. (2017) Performance of the CKD-EPI Equation to Estimate GFR in a Longitudinal Study of Autosomal Dominant Polycystic Kidney Disease. Am J Kidney Dis 69:482-484
Kline, Timothy L; Korfiatis, Panagiotis; Edwards, Marie E et al. (2017) Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease. Kidney Int 92:1206-1216
Kim, Youngwoo; Bae, Sonu K; Cheng, Tianming et al. (2016) Automated segmentation of liver and liver cysts from bounded abdominal MR images in patients with autosomal dominant polycystic kidney disease. Phys Med Biol 61:7864-7880
Porath, Binu; Gainullin, Vladimir G; Cornec-Le Gall, Emilie et al. (2016) Mutations in GANAB, Encoding the Glucosidase II? Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease. Am J Hum Genet 98:1193-1207
Heyer, Christina M; Sundsbak, Jamie L; Abebe, Kaleab Z et al. (2016) Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol 27:2872-84
Kim, Youngwoo; Ge, Yinghui; Tao, Cheng et al. (2016) Automated Segmentation of Kidneys from MR Images in Patients with Autosomal Dominant Polycystic Kidney Disease. Clin J Am Soc Nephrol 11:576-84
Irazabal, María V; Rangel, Laureano J; Bergstralh, Eric J et al. (2015) Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials. J Am Soc Nephrol 26:160-72

Showing the most recent 10 out of 29 publications